Loading, Please Wait...

CST: 16/12/2019 01:47:12   

OmniComm Launches TrialOne® Express for Early Stage Research

257 Days ago

Preset configurations facilitate rapid deployment of early stage studies

Fort Lauderdale, Fla., April 02, 2019 (GLOBE NEWSWIRE) -- Early stage researchers, including Phase I Clinics and Units, with limited resources now have access to a new eClinical research option designed to accelerate and enhance clinical operations. OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, has launched TrialOne Express, (T1xpress), a prefab eClinical solution for Phase I clinic automation.

T1xpress provides preset configurations that will enable researchers with limited resources to automate their facilities and quickly launch clinical studies. These features include a preconfigured library, barcoded label templates, preset system roles and recruitment screens.

Additionally, T1xpress also provides data capture, sample tracking, data exporting and Exago custom reporting hosted in the OmniCloud™. OmniComm will offer three locations for hosting support, with regional offices in the U.S., Europe and China. The package also includes standard process workflow diagrams, a validation starter kit and a “quick-start” implementation schedule.

“OmniComm’s TrialOne solution has been widely recognized as the most functionally robust Phase I clinic automation solution in the industry,” said Stephen Johnson, president and CEO of OmniComm. “However, the level of effort to implement such a robust solution and the hardware requirements necessary to host it have, in some cases, put it out of reach for some smaller Phase I clinics. This new prepackaged and fully hosted turnkey solution will allow for a much shorter implementation schedule, affording these smaller clinics all the benefits of a tier I solution at a much lower total cost of ownership.”

About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, research organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information, and follow OmniComm on Twitter: @OmniCommSystems, LinkedIn: @OmniComm Systems and Facebook: @OmniComm Systems, Inc.

Trademarks
OmniComm, TrialMaster, TrialOne and OmniCloud are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.

Contact Info
Kuno van der Post, Ph.D. 
OmniComm Systems, Inc. 
+1.954.473.1254
KvanderPost@omnicomm.com

Is your business listed correctly on America’s largest city directory network of 1,000 portals?